Zydus Therapeutics Inc.
Details
About Zydus Therapeutics Inc.
Zydus Therapeutics Inc. is a clinical stage, specialty-focused bio-pharmaceutical company dedicated to developing transformative treatments for rare and serious liver diseases and anemias. The company's lead drug candidate, Saroglitazar, is an investigational treatment that has received Fast Track and orphan drug designations from the US FDA for primary biliary cholangitis (PBC). Additionally, Zydus is developing Desidustat, an oral hypoxia-inducible factor prolyl hydroxylase inhibitor for chemotherapy-induced anemia.
Career Opportunities
Zydus Therapeutics Inc. offers a dynamic working environment with opportunities for professional growth in the bio-pharmaceutical industry. Employees are encouraged to contribute to innovative healthcare solutions that empower patients to live healthier lives.
- Remote work options available
- Opportunities for global travel
- Focus on employee development and training
